Urolithiasis Recruiting Phase 4 Trials for Potassium citrate (DB09125)

Also known as: Urolithiases / Urolithiasis (N20-N23) / Urolith

IndicationStatusPhase
DBCOND0032691 (Urolithiasis)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03007160A Study on the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or RecurrencePrevention